Comparison of the Anti-Platelet and Anti-Thrombotic Effects of the Dual SGLT1/2 Inhibitor Sotagliflozin to the Relatively Selective SGLT2 Inhibitor EmpagliflozinLivia Stanger, Michael Holinstat, Bertram Pitt et al.|Blood|2024Cited by 5